4//SEC Filing
Smith David V 4
Accession 0001140361-22-007684
CIK 0001865494other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:30 PM ET
Size
5.0 KB
Accession
0001140361-22-007684
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Smith David V
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+28,019→ 28,019 totalExercise: $6.89Exp: 2032-03-01→ Common Stock (28,019 underlying)
Footnotes (1)
- [F1]These options vest monthly over three years from the vesting commencement date of March 1, 2022, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001229447
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:30 PM ET
- Size
- 5.0 KB